← Scoopfeeds — Intelligent news, curated.
international

Abivax shares jump 36% as new trial data support ulcerative colitis drug obefazimod

Euronews · Jun 30, 2026, 12:59 PM · Also reported by 2 other sources

Why this matters: an international story with cross-border implications worth tracking.

French biotech company Abivax said new clinical trial data supports the safety and effectiveness of its experimental ulcerative colitis treatment.

Read full story on Euronews → More top stories

Also covered by

Investing.com Moleculin reports positive interim data from AML trial Investing.com Guggenheim reiterates Abivax stock rating on cancer data

More in international

The Hindu
Andhra Pradesh aims to emerge as national model in digital connectivity, says Naidu
The Hindu
Retiring senior IPS officer honours late batchmate with tribute cycle ride
The Hindu
Markapuram plans 63,000 hectare horticulture expansion over three years
The Hindu
NHAI approves four pedestrian underpasses along NH 66
The Hindu
HYDRAA fishes out massive amount of waste from city drains

Browse all international coverage →

Aggregated and edited by the Scoop newsroom. We surface news from Euronews alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop